Strategy

Mar 01, 2013
Pharmaceutical Executive
Timely engagement is the key to expanding the use of companion diagnostics.
Mar 01, 2013
Pharmaceutical Executive
A proactive approach to talent and organization planning is the hidden trump card in prevailing with payers.
Mar 01, 2013
Pharmaceutical Executive
Ken Getz of the Tufts University Center for the Study of Drug Development (CSDD) explains how building a stakeholder outreach agenda around the community pharmacist can lead to a better outcome in managing the complex ins and outs of a trial protocol.
Mar 01, 2013
Pharmaceutical Executive
Companies that adopt this new methodology will have a longstanding competitive advantage over those companies conducting business as usual.
Feb 01, 2013
Pharmaceutical Executive
"Drug Life Optimization" can wrest more value through strategies that build a drug's brand franchise through its entire lifespan, according to Stan Bernard.
Jan 01, 2013
Pharmaceutical Executive
New research sheds fresh light on a trend with serious consequences for the public health—not only in the United States but for patients worldwide.
Nov 01, 2012
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Chinese start-ups have realized that they need to recruit highly skilled and globally oriented general managers from foreign multinationals when they reach a critical size.
Nov 01, 2012
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Unified payer research planning is of top import.
Oct 04, 2012
By Pharmaceutical Executive Editors
Oct 01, 2012
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Pharmaceutical companies looking to wrest market share in high growth markets of tomorrow must overcome challenges from a new crop of national champions.
native1_300x100
lorem ipsum